Bio & Insurance Information

Dr. Harold Chapman is a specialist in pulmonology based in San Francisco, California and works at several hospitals in the area, including UCSF Medical Center and San Francisco General Hospital and Trauma Center. He got his diploma from University of Alabama School of Medicine and did his residency in internal medicine at the University of Utah, where he also completed his fellowship in infectious disease. The doctor is certified in critical care medicine, internal medicine, and pulmonary disease and has an experience of more than 20 years.


Insurance Accepted

AetnaMultiPlanUnited Healthcare


Education & Training

University of Alabama

Medical School

University of Utah

Residency

University of Utah

Fellowship

Board Certifications

American Board of Internal Medicine - Pulmonary Disease

Hospitals & Clinics

San Francisco General Hospital

Languages: English/Spanish

(415) 206-8000

1001 Potrero Ave

San Francisco, California 94110

Read More

UCSF Medical Center

Languages: English/Spanish

(415) 353-1037

505 Parnassus Ave

San Francisco, California 94143

Read More

Publications

Dr. Harold Chapman has contributed to 3 publications.

Innate Antiviral Host Defense Attenuates TGF-β Function through IRF3-Mediated Suppression of Smad Signaling.

Xu, P.,Bailey-Bucktrout, S.,Xi, Y.,Xu, D.,Du, D.,Zhang, Q.,Xiang, W.,Liu, J.,Melton, A.,Sheppard, D.,Chapman, H. A.,Bluestone, J. A.,Derynck, R.; Mol. Cell. 2014 Dec 20.

See more >>

Lineage-negative progenitors mobilize to regenerate lung epithelium after major injury.

Vaughan, A. E.,Brumwell, A. N.,Xi, Y.,Gotts, J. E.,Brownfield, D. G.,Treutlein, B.,Tan, K.,Tan, V.,Liu, F. C.,Looney, M. R.,Matthay, M. A.,Rock, J. R.,Chapman, H. A.; Nature. 2014 Dec 24.

See more >>

Identification of pY654-β-catenin as a critical co-factor in hypoxia-inducible factor-1α signaling and tumor responses to hypoxia.

Xi, Y.,Wei, Y.,Sennino, B.,Ulsamer, A.,Kwan, I.,Brumwell, A. N.,Tan, K.,Aghi, M. K.,McDonald, D. M.,Jablons, D. M.,Chapman, H. A.; Oncogene. 2012 Dec 19.

See more >>